Literature DB >> 34583806

Characterization of sleep-disordered breathing in children with Duchenne muscular dystrophy by the American Academy of Sleep Medicine criteria vs disease-specific criteria: what are the differences?

Manju S Hurvitz1, Kanokkarn Sunkonkit2,3, Colin Massicotte2, Rhondda Li2, Rakesh Bhattacharjee1, Reshma Amin2.   

Abstract

STUDY
OBJECTIVES: Individuals with Duchenne muscular dystrophy (DMD) frequently develop sleep-disordered breathing. Noninvasive ventilation is often prescribed for sleep-disordered breathing treatment based on the American Academy of Sleep Medicine (AASM) criteria. In 2018, DMD disease-specific criteria for sleep-disordered breathing were established. Our study aimed to examine the clinical interpretation differences using these different criteria.
METHODS: We performed a multicenter, retrospective chart review of children with DMD followed at The Hospital for Sick Children, Toronto, Canada, and Rady Children's Hospital, San Diego, California, who underwent polysomnography from August 1, 2012, to February 29, 2020. Baseline characteristics and polysomnography data were summarized using descriptive statistics. Agreement for the diagnosis of sleep-disordered breathing evaluated by kappa statistics and sensitivity/specificity analysis was assessed.
RESULTS: One hundred five male children with DMD (mean ± SD age: 12.1 ± 3.8 years; body mass index z score: 0.2 ± 2.3) were included. The proportions of children with DMD that met at least 1 AASM criterion and at least 1 DMD criterion were 45.7% and 67.6%, respectively. We found that 32.4% of children met neither AASM nor DMD criteria. Overall agreement between AASM and DMD criteria was moderate (k = 0.57). There was almost perfect agreement in sleep apnea diagnosis (k = 0.90); however, there was only slight agreement in hypoventilation diagnosis (k = 0.12) between AASM and DMD criteria.
CONCLUSIONS: There were more children with DMD diagnosed with nocturnal hypoventilation and prescribed noninvasive ventilation using DMD criteria compared with AASM criteria. Future studies should address whether the prescription of noninvasive ventilation for children with DMD based on both criteria is associated with different clinical outcomes. CITATION: Hurvitz MS, Sunkonkit K, Massicotte C, Li R, Bhattacharjee R, Amin R. Characterization of sleep-disordered breathing in children with Duchenne muscular dystrophy by the American Academy of Sleep Medicine criteria vs disease-specific criteria: what are the differences? J Clin Sleep Med. 2022;18(2):609-615.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  Duchenne muscular dystrophy; hypoventilation; obstructive sleep apnea; sleep-disordered breathing

Mesh:

Year:  2022        PMID: 34583806      PMCID: PMC8804981          DOI: 10.5664/jcsm.9678

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  31 in total

1.  British Thoracic Society guideline for respiratory management of children with neuromuscular weakness.

Authors:  Jeremy Hull; Roona Aniapravan; Elaine Chan; Michelle Chatwin; Julian Forton; Jayne Gallagher; Neil Gibson; Jill Gordon; Imelda Hughes; Renee McCulloch; Robert Ross Russell; Anita Simonds
Journal:  Thorax       Date:  2012-07       Impact factor: 9.139

Review 2.  Family-Centered Rounds: Past, Present, and Future.

Authors:  Lauren A Destino; Samir S Shah; Brian Good
Journal:  Pediatr Clin North Am       Date:  2019-05-23       Impact factor: 3.278

3.  Impact of Noninvasive Ventilation on Lung Volumes and Maximum Respiratory Pressures in Duchenne Muscular Dystrophy.

Authors:  Dante Brasil Santos; Isabelle Vaugier; Ghilas Boussaïd; David Orlikowski; Hélène Prigent; Frédéric Lofaso
Journal:  Respir Care       Date:  2016-10-18       Impact factor: 2.258

4.  Factors Associated with Changes in Invasive and Noninvasive Positive Airway Pressure Therapy Settings during Pediatric Polysomnograms.

Authors:  Suhail Al-Saleh; Priya Sayal; Derek Stephens; Joshua Florence; Aman Sayal; Adele Baker; Faiza Syed; Indra Narang; Reshma Amin
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

5.  A Family-Centered Rounds Checklist, Family Engagement, and Patient Safety: A Randomized Trial.

Authors:  Elizabeth D Cox; Gwen C Jacobsohn; Victoria P Rajamanickam; Pascale Carayon; Michelle M Kelly; Tosha B Wetterneck; Paul J Rathouz; Roger L Brown
Journal:  Pediatrics       Date:  2017-05       Impact factor: 7.124

6.  Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

7.  Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival.

Authors:  John R Bach; Daniel Martinez
Journal:  Respir Care       Date:  2011-02-11       Impact factor: 2.258

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Benjamin A Alman; Susan D Apkon; Angela Blackwell; Laura E Case; Linda Cripe; Stasia Hadjiyannakis; Aaron K Olson; Daniel W Sheehan; Julie Bolen; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

9.  MPV promote adherence to nocturnal NIV in a Duchenne patient.

Authors:  Anna Annunziata; Antonietta Coppola; Antonella Marotta; Giuseppe Fiorentino
Journal:  Acta Myol       Date:  2020-06-01

10.  Factors influencing communication and decision-making about life-sustaining technology during serious illness: a qualitative study.

Authors:  Jennifer Kryworuchko; P H Strachan; E Nouvet; J Downar; J J You
Journal:  BMJ Open       Date:  2016-05-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.